Liraglutide studies: 1,219 papers with results
Page 2 of 25
- Liraglutide for Children 6 to <12 Years of Age with Obesity - A Randomized Trial.
Fox CK · The New England journal of medicine · 2025
Randomized controlled trial · 6 results
- Adjunctive liraglutide treatment in patients with persistent or recurrent type 2 diabetes after metabolic surgery (GRAVITAS): a randomised, double-blind, placebo-controlled trial.
Miras AD · The lancet. Diabetes & endocrinology · 2019
Randomized controlled trial · 3 results
- Effects of Liraglutide on Reperfusion Injury in Patients With ST-Segment-Elevation Myocardial Infarction.
Chen WR · Circulation. Cardiovascular imaging · 2016
Randomized controlled trial · 5 results
- Pharmacodynamic characteristics of lixisenatide once daily versus liraglutide once daily in patients with type 2 diabetes insufficiently controlled on metformin.
Kapitza C · Diabetes, obesity & metabolism · 2013
Randomized controlled trial · 25 results
- Effect of Adding Liraglutide vs Placebo to a High-Dose lnsulin Regimen in Patients With Type 2 Diabetes: A Randomized Clinical Trial.
Vanderheiden A · JAMA internal medicine · 2016
Randomized controlled trial · 8 results
- Safety and Efficacy of Liraglutide, 3.0 mg, Once Daily vs Placebo in Patients With Poor Weight Loss Following Metabolic Surgery: The BARI-OPTIMISE Randomized Clinical Trial.
Mok J · JAMA surgery · 2023
Randomized controlled trial · 5 results
- Liraglutide enhances insulin secretion and prolongs the remission period in adults with newly diagnosed type 1 diabetes (the NewLira study): A randomized, double-blind, placebo-controlled trial.
Dejgaard TF · Diabetes, obesity & metabolism · 2024
Randomized controlled trial · 7 results
- The effect of SGLT2 inhibitors, GLP1 agonists, and their sequential combination on cardiometabolic parameters: A randomized, prospective, intervention study.
Bechlioulis A · Journal of diabetes and its complications · 2023
Randomized controlled trial · 15 results
- Effect of liraglutide on ambulatory blood pressure in patients with hypertension and type 2 diabetes: A randomized, double-blind, placebo-controlled trial.
Liakos A · Diabetes, obesity & metabolism · 2019
Randomized controlled trial · 5 results
- COMPARISON OF THE LONG-TERM EFFECTS OF LIRAGLUTIDE AND GLIMEPIRIDE MONOTHERAPY ON BONE MINERAL DENSITY IN PATIENTS WITH TYPE 2 DIABETES.
Gilbert MP · Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists · 2016
Randomized controlled trial · 1 result
- A randomized, open-label, active comparator trial assessing the effects of 26 weeks of liraglutide or sitagliptin on cardiovascular function in young obese adults with type 2 diabetes.
Webb DR · Diabetes, obesity & metabolism · 2020
Randomized controlled trial · 6 results
- Bone resorption is unchanged by liraglutide in type 2 diabetes patients: A randomised controlled trial.
Hygum K · Bone · 2020
Randomized controlled trial · 4 results
- Liraglutide in Obese or Overweight Individuals With Stable Bipolar Disorder.
McElroy SL · Journal of clinical psychopharmacology · 2024
Randomized controlled trial · 8 results
- Comparison of glucose control by added liraglutide to only insulin infusion in diabetic patient undergoing cardiac surgery: A preliminary randomized-controlled trial.
Sindhvananda W · Annals of cardiac anaesthesia · 2023
Randomized controlled trial · 5 results
- The Liraglutide Effects in Atrial Fibrillation (LEAF) Study.
Goldberger JJ · JACC. Clinical electrophysiology · 2026
Randomized controlled trial · 8 results
- Pancreatic Effects of Liraglutide or Sitagliptin in Overweight Patients With Type 2 Diabetes: A 12-Week Randomized, Placebo-Controlled Trial.
Smits MM · Diabetes care · 2017
Randomized controlled trial · 8 results
- Treatment with a GLP-1 receptor agonist diminishes the decrease in free plasma leptin during maintenance of weight loss.
Iepsen EW · International journal of obesity (2005) · 2015
Randomized controlled trial · 7 results
- Safety and efficacy of liraglutide versus colesevelam for the treatment of bile acid diarrhoea: a randomised, double-blind, active-comparator, non-inferiority clinical trial.
Kårhus ML · The lancet. Gastroenterology & hepatology · 2022
Randomized controlled trial · 3 results
- Liraglutide and the preservation of pancreatic β-cell function in early type 2 diabetes: the LIBRA trial.
Retnakaran R · Diabetes care · 2014
Randomized controlled trial · 5 results
- Absence of QTc prolongation in a thorough QT study with subcutaneous liraglutide, a once-daily human GLP-1 analog for treatment of type 2 diabetes.
Chatterjee DJ · Journal of clinical pharmacology · 2009
Randomized controlled trial · 3 results
- Liraglutide reverses pronounced insulin-associated weight gain, improves glycaemic control and decreases insulin dose in patients with type 2 diabetes: a 26 week, randomised clinical trial (ELEGANT).
de Wit HM · Diabetologia · 2014
Randomized controlled trial · 6 results
- Does liraglutide alleviate inflammation in brain-dead donors? A randomized clinical trial.
Custódio G · Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society · 2024
Randomized controlled trial · 8 results
- Effects of the once-daily GLP-1 analog liraglutide on gastric emptying, glycemic parameters, appetite and energy metabolism in obese, non-diabetic adults.
van Can J · International journal of obesity (2005) · 2014
Randomized controlled trial · 20 results
- Bone Health After Exercise Alone, GLP-1 Receptor Agonist Treatment, or Combination Treatment: A Secondary Analysis of a Randomized Clinical Trial.
Jensen SBK · JAMA network open · 2024
Randomized controlled trial · 6 results
- Pancreatic beta cell function following liraglutide-augmented weight loss in individuals with prediabetes: analysis of a randomised, placebo-controlled study.
Kim SH · Diabetologia · 2014
Randomized controlled trial · 8 results
- A phase I study comparing the pharmacokinetics of the biosimilar (RD12014) with liraglutide (Victoza) in healthy Chinese male subjects.
Zhou R · Clinical and translational science · 2022
Randomized controlled trial · 5 results
- Liraglutide and Weight Loss Among Suboptimal Responders to Metabolic Bariatric Surgery: A Randomized Clinical Trial.
Brown WA · JAMA network open · 2025
Randomized controlled trial · 3 results
- Effects of liraglutide on gallbladder emptying: A randomized, placebo-controlled trial in adults with overweight or obesity.
Nexøe-Larsen CC · Diabetes, obesity & metabolism · 2018
Randomized controlled trial · 7 results
- Effect of Liraglutide on Cardiovascular Function and Myocardial Tissue Characteristics in Type 2 Diabetes Patients of South Asian Descent Living in the Netherlands: A Double-Blind, Randomized, Placebo-Controlled Trial.
Paiman EHM · Journal of magnetic resonance imaging : JMRI · 2020
Randomized controlled trial · 9 results
- Efficacy and safety of liraglutide monotherapy compared with metformin in Japanese overweight/obese patients with type 2 diabetes.
Tanaka K · Endocrine journal · 2015
Randomized controlled trial · 7 results
- Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study.
Armstrong MJ · Lancet (London, England) · 2016
Randomized controlled trial · 7 results
- Counter-regulatory hormone responses to hypoglycaemia in people with type 1 diabetes after 4 weeks of treatment with liraglutide adjunct to insulin: a randomized, placebo-controlled, double-blind, crossover trial.
Pieber TR · Diabetes, obesity & metabolism · 2015
Randomized controlled trial · 10 results
- Liraglutide reduces hyperglycaemia and body weight in overweight, dysregulated insulin-pump-treated patients with type 1 diabetes: The Lira Pump trial-a randomized, double-blinded, placebo-controlled trial.
Dejgaard TF · Diabetes, obesity & metabolism · 2020
Randomized controlled trial · 5 results
- Comparative effects of weight loss and incretin-based therapies on vascular endothelial function, fibrinolysis and inflammation in individuals with obesity and prediabetes: A randomized controlled trial.
Mashayekhi M · Diabetes, obesity & metabolism · 2023
Randomized controlled trial · 7 results
- Effects of the glucagon-like peptide-1 receptor agonist liraglutide on systolic function in patients with coronary artery disease and type 2 diabetes: a randomized double-blind placebo-controlled crossover study.
Kumarathurai P · Cardiovascular diabetology · 2016
Randomized controlled trial · 5 results
- Effects of liraglutide on weight, satiation, and gastric functions in obesity: a randomised, placebo-controlled pilot trial.
Halawi H · The lancet. Gastroenterology & hepatology · 2017
Randomized controlled trial · 11 results
- Twelve-Week Treatment With Liraglutide as Add-on to Insulin in Normal-Weight Patients With Poorly Controlled Type 1 Diabetes: A Randomized, Placebo-Controlled, Double-Blind Parallel Study.
Frandsen CS · Diabetes care · 2015
Randomized controlled trial · 9 results
- Metabolic improvement with short-term, glucagon-like peptide-1 receptor agonist treatment does not improve cardiac diastolic dysfunction in patients with type 2 diabetes: A randomized, double-blind, placebo-controlled trial.
Bojer AS · Diabetes, obesity & metabolism · 2021
Randomized controlled trial · 9 results
- Liraglutide treatment reduced interleukin-6 in adults with type 1 diabetes but did not improve established autonomic or polyneuropathy.
Brock C · British journal of clinical pharmacology · 2019
Randomized controlled trial · 7 results
- GLP-1 Receptor Agonist Treatment Increases Bone Formation and Prevents Bone Loss in Weight-Reduced Obese Women.
Iepsen EW · The Journal of clinical endocrinology and metabolism · 2015
Randomized controlled trial · 6 results
- Liraglutide Treatment Does Not Induce Changes in the Peripapillary Retinal Nerve Fiber Layer Thickness in Patients with Diabetic Retinopathy.
Arendt Nielsen T · Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics · 2022
Randomized controlled trial · 4 results
- A 12-week treatment with the long-acting glucagon-like peptide 1 receptor agonist liraglutide leads to significant weight loss in a subset of obese women with newly diagnosed polycystic ovary syndrome.
Jensterle M · Hormones (Athens, Greece) · 2015
Randomized controlled trial · 9 results
- A Single-dose, Two-Period Crossover Bioequivalence Study Comparing Two Liraglutide Formulations in Healthy Chinese Subjects.
Feng S · Clinical pharmacology in drug development · 2023
Randomized controlled trial · 4 results
- Liraglutide for Weight Management in Children and Adolescents With Prader-Willi Syndrome and Obesity.
Diene G · The Journal of clinical endocrinology and metabolism · 2022
Randomized controlled trial · 6 results
- Improvement in treatment satisfaction after switching from liraglutide to dulaglutide in patients with type 2 diabetes: A randomized controlled trial.
Takase T · Journal of diabetes investigation · 2019
Randomized controlled trial · 10 results
- The effect of liraglutide on renal function: A randomized clinical trial.
von Scholten BJ · Diabetes, obesity & metabolism · 2017
Randomized controlled trial · 9 results
- Laparoscopic adjustable gastric banding with liraglutide in adults with obesity and type 2 diabetes (GLIDE): a pilot randomised placebo controlled trial.
Coelho C · International journal of obesity (2005) · 2023
Randomized controlled trial · 5 results
- Liraglutide effects in a paediatric (7-11 y) population with obesity: A randomized, double-blind, placebo-controlled, short-term trial to assess safety, tolerability, pharmacokinetics, and pharmacodynamics.
Mastrandrea LD · Pediatric obesity · 2019
Randomized controlled trial · 7 results
- Effect of liraglutide on physical performance in type 2 diabetes: Results of a randomized, double-blind, controlled trial (LIPER2).
Wägner AM · Diabetes & metabolism · 2019
Randomized controlled trial · 7 results
- Liraglutide Augments Weight Loss After Laparoscopic Sleeve Gastrectomy: a Randomised, Double-Blind, Placebo-Control Study.
Thakur U · Obesity surgery · 2021
Randomized controlled trial · 5 results